PET Scans for Decision-Making in Metastatic Renal Cell Carcinoma: A Single-Institution Evaluation-Reference-Cited by-同舟云学术

PET Scans for Decision-Making in Metastatic Renal Cell Carcinoma: A Single-Institution Evaluation

Published:2006 Issue:5 Volume:70 Page:339-344
ISSN:0030-2414
Container-title:Oncology
language:en
Short-container-title:Oncology

Author:

Dilhuydy M.S.,Durieux A.,Pariente A.,de Clermont H.,Pasticier G.,Monteil J.,Ravaud A.

Publisher

S. Karger AG

Subject

Cancer Research,Oncology,General Medicine

Reference13 articles.

1. Linehan WM, Bates SE, Yang JC: Cancer of the kidney and ureter; in DeVita VT Jr, Helmann S, Rosenberg SA (eds): Cancer: Principles and Practice of Oncology, ed 7. Philadelphia, Lippincott Williams and Wilkins, 2004, pp 1139-1167.

2. Renal-Cell Carcinoma

3. Present achievements in the medical treatment of metastatic renal cell carcinoma

4. Long-term response data for 255 patients with metastatic renal cell carcinoma treated with high-dose recombinant interleukin-2 therapy.

5. Recombinant Human Interleukin-2, Recombinant Human Interferon Alfa-2a, or Both in Metastatic Renal-Cell Carcinoma

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Imaging for Renal Cell Carcinoma;Renal Cancer;2019-10-17

2. Fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: A diagnostic imaging modality in renal cancer patients;The Egyptian Journal of Radiology and Nuclear Medicine;2017-12

3. Advances in medical imaging for the diagnosis and management of common genitourinary cancers;Urologic Oncology: Seminars and Original Investigations;2017-07

4. Imaging Features of Renal Cell Carcinoma Differential Diagnosis, Staging, and Posttreatment Evaluation;Renal Cell Carcinoma;2017

5. Physical Examination, Laboratory and Radiological Investigations;Urological Cancer Management;2015